ArticleFrontiers in sociology2026
Structural violence, decolonization and harm reduction in prisons: a critical perspective on opioid use disorders, gender and race.
Article in Frontiers in sociology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substance use remains highly prevalent among prison populations. The war on drugs represents an ethical failure that has not achieved its intended goals. Redirecting resources toward reducing inequality and improving living conditions for citizens could prove more effective in addressing substance use than punitive approaches. Scientific literature consistently shows that prisoners are denied access to healthcare and face discrimination based on race, class, and gender. Continued efforts are needed to raise awareness about the benefits of opioid substitution treatment and needle exchange programs, which help reduce mortality by lowering the risk of overdose after release. Combating corruption, both inside and outside prisons, must be considered a priority. If the prevalence of drug use among incarcerated populations continues to rise, why has there been no reform of a policy long recognized as ineffective and profoundly harmful to prisoners? Who benefits from this?
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.